Improved immunodetection of endogenous α-synuclein

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Lee, Byung Rho ^a   Kamitani, Tetsu ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; MONOMER; PARAFORMALDEHYDE; SERINE; FORMALDEHYDE; POLYMER;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CELL TYPE; CONTROLLED STUDY; EMBRYO; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; IMMUNODETECTION; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MEMBRANE COMPONENT; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PROCESS OPTIMIZATION; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANIMAL; CELL LINE; METHODOLOGY; PHOSPHORYLATION; STANDARD; TISSUE DISTRIBUTION;

ALPHA-SYNUCLEIN; ANIMALS; CELL LINE; FORMALDEHYDE; HUMANS; IMMUNOBLOTTING; MICE; PHOSPHORYLATION; POLYMERS; TISSUE DISTRIBUTION;

EID: 80051855646     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023939     Document Type: Article

References (16)

1. Maroteaux L, Campanelli JT, Scheller RH, (1988) Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8: 2804-2815.
2. Auluck PK, Caraveo G, Lindquist S, (2010) α-Synuclein: membrane interactions and toxicity in Parkinson's disease. Annu Rev Cell Dev Biol 26: 211-233.
3. Bennett MC, (2005) The role of α-synuclein in neurodegenerative diseases. Pharmacol Ther 105: 311-331.
4. McFarland MA, Ellis CE, Markey SP, Nussbaum RL, (2008) Proteomics analysis identifies phosphorylation-dependent α-synuclein protein interactions. Mol Cell Proteomics 7: 2123-2137.
5. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al. (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047.
6. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, et al. (1998) Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat Genet 18: 106-108.
7. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, et al. (2003) α-Synuclein locus triplication causes Parkinson's disease. Science 302: 841.
8. Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, et al. (2004) The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55: 164-173.
9. Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, et al. (2002) α-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4: 160-164.
10. Tanji K, Tanaka T, Mori F, Kito K, Takahashi H, et al. (2006) NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1. Am J Pathol 169: 553-565.
11. Matsuo Y, Kamitani T, (2010) Parkinson's disease-related protein, α-synuclein, in malignant melanoma. PLoS One 5: e10481.
12. Suzuki Y, Takeda Y, Ikuta T, (2008) Immunoblotting conditions for human hemoglobin chains. Anal Biochem 378: 218-220.
13. Jakes R, Crowther RA, Lee VM, Trojanowski JQ, Iwatsubo T, et al. (1999) Epitope mapping of LB509, a monoclonal antibody directed against human α-synuclein. Neurosci Lett 269: 13-16.
14. Anderson JP, Walker DE, Goldstein JM, de Laat R, Banducci K, et al. (2006) Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease. J Biol Chem 281: 29739-29752.
15. Lauritzen E, Pluskal M, (1988) Improved HIV antiglycoprotein antibody detection by immunoblotting on a hydrophobic membrane. J Acquir Immune Defic Syndr 1: 333-339.
16. Wakamatsu M, Ishii A, Ukai Y, Sakagami J, Iwata S, et al. (2007) Accumulation of phosphorylated α-synuclein in dopaminergic neurons of transgenic mice that express human α-synuclein. J Neurosci Res 85: 1819-1825.